ProQR Therapeutics (PRQR) Revenue (2013 - 2025)
ProQR Therapeutics (PRQR) reported Revenue of $5.5 million for Q4 2025, up 18.57% on a YoY basis from $4.6 million in Q4 2024, and up 61.97% sequentially from $3.4 million in Q3 2025.
ProQR Therapeutics (PRQR) Revenue (2013 - 2025) Analysis & Trends
ProQR Therapeutics (PRQR) has 13 years of Revenue data on file, last reported at $5.5 million in Q4 2025.
- For the quarter ending Q4 2025, Revenue rose 18.57% year-over-year to $5.5 million; the trailing twelve-month figure through Dec 2025 stood at $17.9 million (down 12.45% YoY), and the FY2025 full-year result was $18.5 million, down 8.35% from the prior year.
- Revenue improved to $5.5 million in Q4 2025, from $3.4 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $14.6 million in Q1 2021 to a low of $273409.1 in Q4 2021.
- A 5-year average of $3.3 million and a median of $2.4 million in 2025 frame the typical range for Revenue.
- Across the five-year window, Revenue plunged 98.03% in 2021 and soared 587.63% in 2024, its largest moves.
- Tracing PRQR's Revenue over 5 years: stood at $273409.1 in 2021, then jumped by 168.67% to $734578.1 in 2022, then soared by 381.01% to $3.5 million in 2023, then jumped by 30.26% to $4.6 million in 2024, then increased by 18.57% to $5.5 million in 2025.
- Business Quant data shows PRQR's Revenue at $5.5 million in Q4 2025, $3.4 million in Q3 2025, and $4.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | ProQR Therapeutics | 182.23 Mn | 138.42 Mn | - | 5.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.46 Mn |
| Sep 30, 2025 | 3.37 Mn |
| Jun 30, 2025 | 4.32 Mn |
| Mar 31, 2025 | 4.75 Mn |
| Dec 31, 2024 | 4.60 Mn |
| Sep 30, 2024 | 4.22 Mn |
| Jun 30, 2024 | 6.79 Mn |
| Mar 31, 2024 | 4.83 Mn |
| Dec 31, 2023 | 3.53 Mn |
| Sep 30, 2023 | 1.49 Mn |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 703,038.89 |
| Dec 31, 2022 | 734,578.10 |
| Sep 30, 2022 | 820,735.30 |
| Jun 30, 2022 | 992,362.72 |
| Mar 31, 2022 | 1.27 Mn |
| Dec 31, 2021 | 273,409.06 |
| Sep 30, 2021 | 1.03 Mn |
| Jun 30, 2021 | 292,637.96 |
| Mar 31, 2021 | 14.60 Mn |